Genetic polymorphisms of transforming growth factor-β1 and its receptors and colorectal cancer susceptibility: A population-based case-control study in China

Yongjing Zhang,Bing Liu,Mingjuan Jin,Qin Ni,Xia Liang,Xinyuan Ma,Kaiyan Yao,Qilong Li,Kun Chen
DOI: https://doi.org/10.1016/j.canlet.2008.10.017
IF: 9.756
2009-01-01
Cancer Letters
Abstract:The TGF-β signaling pathway plays a very important role in the control of cell proliferation and differentiation that is involved in colorectal carcinogenesis. The associations between polymorphisms of TGF-β1 and its receptors genes and the colorectal cancer risk were assessed in a population-based case-control study (206 cases and 838 controls). We could not observe any variant in the G-800A, codon25 and codon263 of TGF-β1 and A-364G of TGFβR2 in Chinese population. However, the results revealed that -509CT and TT genotypes were significantly associated with decrease risk for colorectal cancer (adjusted OR=0.58, 95% CI 0.40–0.84 and adjusted OR=0.44, 95% CI 0.29–0.68, respectively). Moreover, the linkage disequilibrium analysis revealed that TGF-β1 C-509T and codon10 polymorphisms were in strong linkage disequilibrium, and the −509C/+29C was associated with a significantly increased risk of colorectal cancer (OR=1.32, 95% CI=1.05–1.66). Our findings indicate that the distributions of polymorphisms in TGF-β1 and its receptors genes vary greatly among different ethnic groups, and these polymorphisms might contribute to the colorectal cancer susceptibility.
What problem does this paper attempt to address?